ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Formation Bio launches a $600 million fund to accelerate AI-powered drug development by acquiring 10 to 15 programs over three to five years. The New York-based company partners with research foundations and hospitals to advance Phase 1 and Phase 2 treatments using shared clinical infrastructure.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Goldman Sachs Launches $500 Million AI Institute